Novavax begins phase 2 COVID-19 vaccine trials in South Africa

American vaccine group Novavax has begun its phase 2 clinical trials in South Africa this week, this trial is supported in part by a $15 million grant from the Bill & Melinda Gates Foundation and will be led by Dr. Shabir Madhi, Professor of Vaccinology at Wits University. Dr. Shabir Madhi joins CNBC Africa for more.

Wed, 19 Aug 2020 11:45:29 GMT
Sign Up for Our Newsletter Daily Update
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.